Artificial Intelligence (AI) in Oncology: Advancing Diagnosis, Treatment, and Prognostic Precision

When you or a loved one is facing cancer, every decision – from diagnosis to treatment – can feel overwhelming. Thankfully, modern technology is helping doctors make faster, more accurate, and more personalized decisions.

One of the most promising tools of recent has been artificial intelligence, also known as AI.

AI is not science fiction. It’s already being used in real cancer clinics to help doctors detect cancer earlier, match patients with the right treatments, and even predict how a disease might behave. In this blog, we’ll break down how AI is helping in the fight against cancer – including rare cancers like mesothelioma – and what it could mean for your care in the future. 

Current Applications: Where AI Is Already Making an Impact?

Detecting Cancer Earlier and More Accurately

AI can help radiologists and pathologists (the doctors who read imaging scans and analyze tissue samples) spot cancer sooner by recognizing patterns in images that the human eye might miss.

• In breast cancer, tools like Google’s LYNA (Lymph Node Assistant) have demonstrated more than 90% accuracy in detecting metastases in lymph node biopsies.
• Lung cancer screening is benefitting from deep learning models that can analyze CT scans with radiologist-level performance.
• For mesothelioma, which is a rare cancer caused by asbestos fibers getting trapped in the body, AI is being applied to improve the reading of chest X-rays, PET scans and even pathology slides, aiding in earlier and more accurate differentiation from other pleural diseases.

Choosing the Right Treatment for Each Person

Cancer isn’t one-size-fits-all, and treatment should be personalized. AI is helping doctors analyze each tumor’s genetic makeup and choose a treatment that targets the specific mutations in an individual’s cancer.

• In colorectal and breast cancers, AI systems help analyze tumor profiles to predict responses to immunotherapy or chemotherapy.
• Emerging models are being trained on rare cancers like mesothelioma, using datasets from global registries to predict which chemotherapy combinations or immunotherapies might yield better responses.

Predicting What Might Happen Next

Doctors are now using AI to help answer questions like “How likely is the cancer to come back?” and “How well will this treatment work?”

• AI platforms like IBM Watson for Oncology, and other academic models using machine learning, can estimate survival curves based on tumor subtype, genetic mutations and even lifestyle choices.
• For aggressive cancers like pancreatic adenocarcinoma or mesothelioma, AI models are aiding clinicians in making informed decisions about palliative care versus aggressive intervention.

The Long-Term Potential of AI in Oncology

Looking ahead, the role of AI in cancer care is expected to expand in several transformative ways:

• Liquid biopsy analysis – AI could help decode complex biomarker patterns from blood samples to detect cancer at the molecular level before symptoms arise.
• Real-time clinical decision support – AI-powered systems may soon assist oncologists in making split-second decisions based on continuously updated research and patient data.
• Global cancer surveillance – AI tools could standardize cancer detection and treatment protocols in low-resource settings, reducing global health disparities.
• Drug discovery acceleration – By modeling molecular interactions, AI can significantly shorten the timeline for identifying viable cancer drugs – even for rare cancers like mesothelioma.

What Are the Risks?

Despite its promise, AI in oncology is not without risks:

• Bias and dataset limitations – Many AI models are trained on datasets that underrepresent certain populations, leading to unequal performance across racial, gender, or geographic lines.
• Overfitting and reproducibility – Algorithms may perform well on training data but fail in real-world clinical settings, especially with heterogeneous cancers like mesothelioma.
• Interpretability – Many AI models function as “black boxes,” making it difficult for clinicians to understand how predictions are made – potentially eroding trust and clinical utility.

What Does It Mean for You? 

If you’re a cancer patient (or caring for one), here’s what you should know:

• Ask your care team if AI tools are part of your treatment. Many major cancer centers already use them.
• Keep an open mind. AI isn’t magic, but it is helping doctors offer more personalized, data-driven care.
• Advocate for transparency. You always deserve to know how decisions are being made about your health.

AI in medicine and cancer treatment is not going away. As technology improves and time progresses, AI will continue to grow its foothold in how we fight cancer and potentially even cure patients.

Sources & Author

1. Liu Y, Kohlberger T, Norouzi M, et al. Artificial Intelligence-Based Breast Cancer Nodal Metastasis Detection: Insights Into the Black Box for Pathologists. Arch Pathol Lab Med. 2019;143(7):859-868. doi:10.5858/arpa.2018-0147-OA.
2. Hendrix, W., Hendrix, N., Scholten, E.T. et al. Deep learning for the detection of benign and malignant pulmonary nodules in non-screening chest CT scans. Commun Med 3, 156 (2023). https://doi.org/10.1038/s43856-023-00388-5.
3. Marchi G, Mercier M, Cefalo J, et al. Advanced imaging techniques and artificial intelligence in pleural diseases: a narrative review. Eur Respir Rev. 2025;34(176):240263. Published 2025 Apr 2. doi:10.1183/16000617.0263-2024.
4. Tacelli M, Lauri G, Tabacelia D, Tieranu CG, Arcidiacono PG, Săftoiu A. Integrating artificial intelligence with endoscopic ultrasound in the early detection of bilio-pancreatic lesions: Current advances and future prospects. Best Pract Res Clin Gastroenterol. 2025;74:101975. doi:10.1016/j.bpg.2025.101975.
5. Yang J, Huang J, Han D, Ma X. Artificial Intelligence Applications in the Treatment of Colorectal Cancer: A Narrative Review. Clin Med Insights Oncol. 2024;18:11795549231220320. Published 2024 Jan 5. doi:10.1177/11795549231220320.
6. Ram M, Afrash MR, Moulaei K, et al. Predicting Mesothelioma Using Artificial Intelligence: A Scoping Review of Common Models and Applications. Technol Cancer Res Treat. 2025;24:15330338251341053. doi:10.1177/15330338251341053.
7. Ginghina O, Hudita A, Zamfir M, et al. Liquid Biopsy and Artificial Intelligence as Tools to Detect Signatures of Colorectal Malignancies: A Modern Approach in Patient’s Stratification. Front Oncol. 2022;12:856575. Published 2022 Mar 8. doi:10.3389/fonc.2022.856575.
8. Verlingue L, Boyer C, Olgiati L, Brutti Mairesse C, Morel D, Blay JY. Artificial intelligence in oncology: ensuring safe and effective integration of language models in clinical practice. Lancet Reg Health Eur. 2024;46:101064. Published 2024 Sep 6. doi:10.1016/j.lanepe.2024.101064.
9. Istasy P, Lee WS, Iansavichene A, et al. The Impact of Artificial Intelligence on Health Equity in Oncology: Scoping Review. J Med Internet Res. 2022;24(11):e39748. Published 2022 Nov 1. doi:10.2196/39748.
10. Tiwari A, Mishra S, Kuo TR. Current AI technologies in cancer diagnostics and treatment. Mol Cancer. 2025;24(1):159. Published 2025 Jun 2. doi:10.1186/s12943-025-02369-9.

About the Writer, Dr. Stephen Williams, Precision Oncology Scientist

Dr. Stephen Williams is a Precision Oncology Scientist in the Department of Pathology and Laboratory Medicine at MD Anderson Cancer Center in Houston, Texas. Dr. Williams has served as a medical reviewer, guest blog writer, and medical content writer for Mesothelioma Guide since 2024. He helps the organization inform and educate patients and loved ones about cancer treatment – ensuring all content published on the Mesothelioma Guide website is accurate, concise, and clear.